Overview
Stage 4 Follicular Lymphoma is when the cancer has spread beyond the lymph nodes to other organs such as your liver, bone marrow, or lungs.
Tap “Watch Now” for an easy-to-understand overview of Stage 4 Follicular Non-Hodgkin Lymphoma.
- Stage 4 Follicular Non Hodgkin Lymphoma Cancer Diagnosis
Overview
Follicular Lymphoma is the most common type of slow growing, Non-Hodgkin Lymphoma. It begins in your B lymphocytes, the white blood cells that help your body fight infection.
A Stage 4 Adult Non-Hodgkin Lymphoma diagnosis means that the cancer has spread to one or more of your tissues or organs outside of the lymph system. This spread may include organs such as the liver, lungs or bones, and may be found in your lymph nodes near or far away from those organs as well.
What Tests Will I Need and Why?
Blood tests and imaging such as a CT scan and/or a PET scan are done to understand your general health, confirm your diagnosis and determine your cancer stage.
Tissue analysis in the form of a core needle biopsy or excisional biopsy is typically done. In some cases, a bone marrow biopsy may be needed.
If your treatment team has not already performed tests to determine your cancer’s features, please ask your doctor when these tests will be performed.
Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.
National Institute of Health/ treatment-lymphoma
Commonly Searched Questions
Stage 4 Non-Hodgkin Lymphoma Definition
The cancer has spread to one or more tissues or organs outside the lymph system, such as the liver, lungs or bones, and may be found in lymph nodes near or far away from those organs.
Source: Cancer.gov
Stage 4 Non-Hodgkin Lymphoma Survival Rate
According to SEER data, Stage 4 Non-Hodgkin Lymphoma has a survival rate of 58.5%. For example, if the 5-year relative survival rate for stage 4 non-hodgkin lymphoma is 58.5%, it means that patients who have that cancer are, on average, about 58.5% as likely as patients who don’t have that cancer to live for at least 5 years after being diagnosed.
Source: Cancer.gov
Stage 4 Non-Hodgkin Lymphoma Symptoms
Signs and symptoms of non-Hodgkin’s lymphoma may include:
- Swollen lymph nodes in your neck, armpits or groin
- Abdominal pain or swelling
- Chest pain, coughing or trouble breathing
- Persistent fatigue
- Fever
- Night sweats
Source: Cancer.gov
Stage 4 Non-Hodgkin Lymphoma Treatment
There are different types of treatment for patients with Non-Hodgkin Lymphoma such as:
- radiation therapy
- chemotherapy
- targeted therapy
- immunotherapy
- plasmapheresis
- stem cell transplant
- surgery
Source: Cancer.gov
Stage 4 Non-Hodgkin Lymphoma Recurrence Rate
Stage 4 non-Hodgkin lymphoma (NHL) is considered advanced and has a higher risk of recurrence compared to earlier stages. Recurrence rates for Stage 4 NHL can vary depending on several factors, including the type of NHL, the specific treatments used, and individual patient characteristics. Generally, Stage 4 NHL indicates that the cancer has spread to distant organs or tissues beyond the lymph nodes. While exact recurrence rates are not always provided in general terms, Stage 4 NHL often requires aggressive treatment and close monitoring due to the higher likelihood of returning. For precise recurrence rates and treatment outcomes, it is essential to consult with a healthcare provider or oncologist.
Source: Cancer.gov
Stage 4 Non-Hodgkin Lymphoma Prevention
Specific prevention strategies for Stage 4 Non-Hodgkin Lymphoma are not detailed. However, general recommendations include:
• Avoid Exposure to Carcinogens: Minimize contact with harmful chemicals.
• Healthy Diet and Weight: Eat a balanced diet and maintain a healthy weight.
• Avoid Infections: Practice good hygiene and get vaccinated when appropriate.
• Healthy Lifestyle: Engage in regular exercise, avoid smoking, and limit alcohol intake.
These steps aim to reduce overall cancer risk and support general health.
Source: Cancer.gov